Actively Recruiting
Effect of L-Carnitine Supplementation in Preterm Neonates
Led by Muhammad Aamir Latif · Updated on 2026-02-27
160
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.
CONDITIONS
Official Title
Effect of L-Carnitine Supplementation in Preterm Neonates
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Preterm neonates
- Both male and female babies
- Diagnosed with Respiratory Distress Syndrome (RDS)
- Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth
You will not qualify if you...
- Neonates with abnormalities of the gastrointestinal tract
- Neonates with confirmed or suspected sepsis at the time of enrollment
- Neonates expected to survive less than 48 hours as judged by the neonatologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Recep Tayyip Erdogan Hospital/Indus Hospital & Health Network
Muzaffargarh, Punjab Province, Pakistan, 32400
Actively Recruiting
Research Team
M
Muhammad Sarfraz, FCPS
CONTACT
A
Athar Razzaq, FCPS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here